Prostacyclin I2 (PGI2) increases left ventricular ejection fraction (LVEF)

This publication has 11 references indexed in Scilit:

• Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man
  European Journal of Clinical Pharmacology, 1987
• A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension
  American Heart Journal, 1985
• Prostaglandin E1 infusion in unstable angina: Effects on anginal frequency and cardiac function
  American Heart Journal, 1984
• LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
  The Lancet, 1984
• Prostaglandin E1coronary venous retroperfusion in acute myocardial ischemia: Effects on regional left ventricular function and infarct size
  Journal of the American College of Cardiology, 1984
• Prostacyclin therapy in patients with congestive heart failure
  The American Journal of Cardiology, 1982
• Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
  Circulation Research, 1981
• Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
  Progress in Cardiovascular Diseases, 1979
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
  Prostaglandins, 1978
• Prostaglandin-induced preservation of the ischemic myocardium.
  Circulation Research, 1978